drugset / Trial / NCT00786994

The Efficacy and Tolerability of Oleogel-S-10 in Patients With Actinic Keratoses

NCT00786994

Phase 2 Completed 165 enrolled Birken AG University Hospital Tuebingen · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

In this study the impact of Oleogel-S-10 versus placebo on actinic keratoses over a treatment period of 3 months will be tested. Additionally, once and twice daily applications are tested.

Timeline

Start
2008-10
Primary completion
2010-11
Completion
2010-11

Drugs

EvaluationDrugModalityDoseRoute
Subject BIRCH TRITERPENES Small molecule 100 unknown Topical

Indications